.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A06A_DrugsForConstipation.A06AH03_Naloxegol.Naloxegol

Information

name:Naloxegol
ATC code:A06AH03
route:oral
n-compartments2

Naloxegol is a peripherally acting mu-opioid receptor antagonist (PAMORA) used for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. It is approved for therapeutic use in multiple regions including the US and EU.

Pharmacokinetics

Pharmacokinetic parameters reported in healthy adult volunteers following single 25 mg oral dose during clinical studies.

References

  1. Hruska, MW, et al., & Marsteller, DA (2024). Population Pharmacokinetics of Naloxegol in Pediatric Subjects Receiving Opioids. Clinical pharmacology in drug development 13(9) 974–984. DOI:10.1002/cpdd.1457 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39110083

  2. Eldon, MA, et al., & Sostek, M (2015). Safety, tolerability, and pharmacokinetics of multiple ascending doses of naloxegol. Clinical pharmacology in drug development 4(6) 442–448. DOI:10.1002/cpdd.204 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27137716

Revisions

Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos